Law360, New York (August 27, 2007, 12:00 AM EDT) -- Despite the protests of Novartis Pharmaceuticals Corp., a federal district judge has granted the request of two plaintiffs to remand their case to state court, sending the suit back to the lower court as the product liability litigation over bone cancer drugs Aredia and Zometa continues to unfold.
On Friday, U.S. District Court Judge Todd Campbell discarded the pharmaceutical giant's objections to Magistrate Judge Joe B. Brown's Aug. 8 recommendation that plaintiffs Joan and Armand Lecompte's motion for remand be granted.
Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.